Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionVTMGX - Vanguard Developed Markets Index Fund Admiral Shares
Latest Disclosed Ownership217,800 shares
Latest Disclosed Value $ 1,993,858
VTMGX - Vanguard Developed Markets Index Fund Admiral Shares ownership in 4577 / Daito Pharmaceutical Co.,Ltd.

On May 28, 2026 - VTMGX - Vanguard Developed Markets Index Fund Admiral Shares filed a NPORT-P form disclosing ownership of 217,800 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $314,938,800 USD as of March 31, 2026. The entity filed a previous NPORT-P on February 26, 2026 disclosing 217,800 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $295,336,800 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-28 2026-03-31 NP DAITO PHARMA EC JP3486150000 217,800 0 0.00 1,994 5.84 0.0007
2026-02-26 2025-12-31 NP DAITO PHARMA EC JP3486150000 217,800 -61,800 -22.10 1,884 -19.01 0.0007
2025-11-25 2025-09-30 NP DAITO PHARMA EC JP3486150000 279,600 71,500 34.36 2,325 61.57 0.0009
2025-08-27 2025-06-30 NP DAITO PHARMA EC JP3486150000 208,100 72,500 53.47 1,439 -27.40 0.0006
2025-05-28 2025-03-31 NP DAITO PHARMA EC JP3486150000 135,600 0 0.00 1,983 10.79 0.0010
2025-02-28 2024-12-31 NP DAITO PHARMA EC JP3486150000 135,600 0 0.00 1,789 -15.77 0.0009
2024-11-26 2024-09-30 NP DAITO PHARMA EC JP3486150000 135,600 30,200 28.65 2,125 45.38 0.0010
2024-08-27 2024-06-30 NP DAITO PHARMA EC JP3486150000 105,400 0 0.00 1,461 -10.09 0.0008
2024-05-29 2024-03-31 NP DAITO PHARMA EC JP3486150000 105,400 0 0.00 1,626 14.28 0.0009
2024-02-29 2023-12-31 NP DAITO PHARMA EC JP3486150000 105,400 0 0.00 1,422 0.00 0.0008
2024-02-29 2023-12-31 NP DAITO PHARMA EC JP3486150000 105,400 0 0.00 1,422 -14.08 0.0008
2023-11-28 2023-09-30 NP DAITO PHARMA EC JP3486150000 105,400 9,581 10.00 1,655 8.52 0.0010
2023-08-28 2023-06-30 NP DAITO PHARMA EC JP3486150000 95,819 0 0.00 1,526 -14.47 0.0009
2023-05-26 2023-03-31 NP DAITO PHARMA EC JP3486150000 95,819 0 0.00 1,784 -1.65 0.0011
2023-03-01 2022-12-31 NP DAITO PHARMA EC JP3486150000 95,819 0 0.00 1,814 11.30 0.0012
2022-11-29 2022-09-30 NP DAITO PHARMA EC JP3486150000 95,819 21,000 28.07 1,629 6.12 0.0013
2022-08-29 2022-06-30 NP DAITO PHARMA EC JP3486150000 74,819 -435 -0.58 1,535 -12.68 0.0011
2022-05-31 2022-03-31 NP DAITO PHARMA EC JP3486150000 75,254 0 0.00 1,758 -9.43 0.0011
2022-03-01 2021-12-31 NP DAITO PHARMA EC JP3486150000 75,254 -368 -0.49 1,942 -14.38 0.0012
2021-11-29 2021-09-30 NP DAITO PHARMA EC JP3486150000 75,622 0 0.00 2,268 -1.35 0.0014
2021-08-30 2021-06-30 NP DAITO PHARMA EC JP3486150000 75,622 0 0.00 2,299 -6.59 0.0015
2021-06-01 2021-03-31 NP DAITO PHARMA EC JP3486150000 75,622 0 0.00 2,460 -9.86 0.0017
2021-03-01 2020-12-31 NP DAITO PHARMA EC JP3486150000 75,622 0 0.00 2,730 7.23 0.0020
2020-11-27 2020-09-30 NP DAITO PHARMA EC JP3486150000 75,622 6,500 9.40 2,546 -0.62 0.0021
2020-08-31 2020-06-30 NP DAITO PHARMA EC JP3486150000 69,122 0 0.00 2,562 35.43 0.0023
2020-06-01 2020-03-31 NP DAITO PHARMA EC JP3486150000 69,122 0 0.00 1,892 -5.87 0.0019
2020-03-02 2019-12-31 NP Daito Pharmaceutical Co. EC JP3486150000 69,122 0 0.00 2,009 3.66 0.0016
2019-11-27 2019-09-30 NP Daito Pharmaceutical Co. EC JP3486150000 69,122 69,122 1,938 0.0017
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.